Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

Sponsor
Hitit University
Study ID
NCT07663097
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
MALE
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Holmium Laser Enucleation of the Prostate (HoLEP) — PROCEDURE
    Standard HoLEP procedure for treatment of benign prostatic hyperplasia.
  • Transurethral Resection of the Prostate (TURP) — PROCEDURE
    Standard TURP procedure for treatment of benign prostatic hyperplasia.

Study Details

Benign prostatic hyperplasia (BPH) is a common condition in older men and may cause bothersome lower urinary tract symptoms that can negatively affect quality of life. Surgical treatment with Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) is often recommended when medical therapy is insufficient. This prospective observational study aims to evaluate whether preoperative anxiety, depression, and surgical fear influence postoperative functional outcomes, urinary continence, erectile function, and patient satisfaction in patients undergoing HoLEP or TURP for BPH. Participants will complete validated psychological and functional questionnaires before surgery and during postoperative follow-up visits at 1 and 3 months. The study will also assess changes in psychological status after surgery and compare outcomes between HoLEP and TURP patients. The findings may help improve preoperative patient counseling and identify patients who could benefit from additional psychological support before surgery.

Key Dates

Start date
Jun 14, 2026
Status verified
Jun 2026
Primary completion
Apr 8, 2027
Completion
Jun 8, 2027

Study Design

Enrollment
80 participants (estimated)

Arms

  • Arm: HoLEP Group
    Patients with benign prostatic hyperplasia undergoing HoLEP surgery.
  • Arm: TURP Group
    Patients with benign prostatic hyperplasia undergoing TURP surgery.

Primary Outcome Measure

Change in International Prostate Symptom Score (IPSS) [ Time Frame: Baseline to 3 months after surgery ]

Central Contacts

Related Studies